We are live on ! Find out more
TGTX icon

TG Therapeutics
TGTX

115 hedge funds and large institutions have $200M invested in TG Therapeutics in 2018 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 43 increasing their positions, 27 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

105% more call options, than puts

Call options by funds: $4.51M | Put options by funds: $2.2M

59% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 27

1.42% more ownership

Funds ownership: 57.56% → 58.98% (+1.4%)

9% less funds holding

Funds holding: 127 → 115 (-12)

25% less capital invested

Capital invested by funds: $267M → $200M (-$66.5M)

41% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 27

Holders
115
Holders Change
-12
Holders Change %
-9.45%
% of All Funds
2.56%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
43
Reduced
27
Closed
27
Calls
$4.51M
Puts
$2.2M
Net Calls
+$2.3M
Net Calls Change
+$4.13M

Top Buyers

Rank Fund Capital Flow
1
BM
Bridger Management
New York
+$7.96M
2
GPP
Great Point Partners
Connecticut
+$5.22M
3
Two Sigma Investments
Two Sigma Investments
New York
+$2.9M
4
ACA
Avoro Capital Advisors
New York
+$2.73M
5
Renaissance Technologies
Renaissance Technologies
New York
+$2.6M

Top Sellers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
-$10.6M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$5.36M
3
Bank of America
Bank of America
North Carolina
-$2.9M
4
NC
Nexthera Capital
New York
-$2.49M
5
HCMT
Highland Capital Management (Texas)
Texas
-$1.49M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of Montreal
101
Bank of Montreal
Ontario, Canada
$4K +$2.2K +443 +102%
LC
102
Lindbrook Capital
California
$4K +$4.97K +1,000 New
SFG
103
SevenBridge Financial Group
Pennsylvania
$4K +$4.97K +1,000 New
RE
104
RBC Europe
United Kingdom
$3.48K – – –
IA
105
IFP Advisors
Florida
$3K -$7.21K -1,450 -66%
Macquarie Group
106
Macquarie Group
Australia
$2K – – –
TWA
107
TCI Wealth Advisors
Arizona
$2K +$1.49K +300 +100%
ED
108
Exane Derivatives
France
$1.78K – – –
Franklin Resources
109
Franklin Resources
California
– -$10.6M -1,892,978 Closed
NC
110
Nexthera Capital
New York
– -$2.49M -445,000 Closed
EU
111
Emory University
Georgia
– -$1.3M -231,989 Closed
Allianz Asset Management
112
Allianz Asset Management
Germany
– -$950K -169,628 Closed
Balyasny Asset Management
113
Balyasny Asset Management
Illinois
– -$574K -102,571 Closed
Invesco
114
Invesco
Georgia
– -$574K -102,476 Closed
GH
115
GAM Holding
Switzerland
– -$552K -98,600 Closed
GTC
116
Ghost Tree Capital
New York
– -$255K -45,500 Closed
BAM
117
Belpointe Asset Management
Nevada
– -$243K -43,435 Closed
MSL
118
Mackay Shields LLC
New York
– -$227K -40,600 Closed
T. Rowe Price Associates
119
T. Rowe Price Associates
Maryland
– -$220K -39,297 Closed
Parallax Volatility Advisers
120
Parallax Volatility Advisers
California
– -$196K -34,986 Closed
CSS
121
Cubist Systematic Strategies
Connecticut
– -$149K -26,598 Closed
CAN
122
Claraphi Advisory Network
United States
– -$123K -22,000 Closed
CM
123
Caption Management
Oklahoma
– -$117K -20,900 Closed
AQR Capital Management
124
AQR Capital Management
Connecticut
– -$95K -16,948 Closed
Janney Montgomery Scott
125
Janney Montgomery Scott
Pennsylvania
– -$90K -15,995 Closed
2 3 4
5
6

TGTX Hedge Fund Activity: Q4 2018 in Review

115 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in TG Therapeutics (TGTX) for Q4 2018, worth a combined $200M — down 25% from $267M a quarter earlier.

Sellers outnumbered buyers: 27 funds closed out of TGTX and 16 opened new positions — a net loss of 11 holders — while 27 trimmed existing stakes and 43 added.

The largest buyer was Bridger Management, adding an estimated $7.96M. The largest seller was Franklin Resources, exiting entirely with an estimated $10.6M sold.

  • 115 institutional investors held TG Therapeutics (TGTX) as of Q4 2018, down from 127 in Q3 2018.
  • Funds reported $200M of TG Therapeutics stock for Q4 2018, down 25% quarter-over-quarter.
  • 16 funds opened new TG Therapeutics positions in Q4 2018 and 27 closed out, a net change of -11 holders.
  • The largest TG Therapeutics buyer in Q4 2018 was Bridger Management, an estimated $7.96M added.
  • The largest TG Therapeutics seller in Q4 2018 was Franklin Resources, an estimated $10.6M sold.

Based on aggregated 13F filings for Q4 2018.